Biosurgery Market Report 2022: Trends, Market Size, Analysis 2026 » S4 Network
JJ
by on 31. October 2022
173 views

The research report on “Global Biosurgery Market” covers the different market scenarios that have a direct impact on the growth of the market. The Global Biosurgery Market was valued at USD 12.2 billion in 2021 and is expected to reach USD 16.0 billion by 2026, expanding at a CAGR of 5.7% by the end of the forecast period. The study includes information on market factors such as the market dynamics, including drivers, restraints, challenges, threats, and the potential growth opportunities, market trends, development patterns, financial information (revenue), latest technologies, innovations, leading competitors, and regional analysis of the market. The market is expected to grow at a significate rate during the forecast period, owing to the demand from all corners of the globe.

In the first section, the report consists of the basic overview of the market, including product definitions, classifications, new product launches, key developments, and the industry chain structure of the overall market. Besides, the report covers intelligence of different segments such as the product type, technology, application, industry vertical, end-user, and geography. In the next section, the report focuses on the industry development policies, plans, production cost, value, volume, import/export, cost structures, supply and value chain analysis, manufacturing processes, and consumption figures. Furthermore, the report highlights the regional and segment-based aspects to access the untapped opportunities in the Global Biosurgery Market. The information is provided in the form of year-to-year evolution and basis point share, I term of CAGR and revenue.

Request a Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=166922302

Prominent Players in Biosurgery Market are:

Johnson & Johnson (US), Baxter International Inc. (US), Medtronic Plc (Ireland), Becton, Dickinson & Co. (US), B. Braun Melsungen AG (Germany), Stryker Corp. (US), Integra Lifesciences Holdings Corp. (US), CSL Ltd. (Australia), Hemostasis LLC. (US), Pfizer Inc. (US), Cyrolife Inc. (US), Zimmer Biomet (US), Kuros Biosciences AG (Switzerland), Orthofix Medical Inc. (US), Smiths & Nephew Plc. (UK) and Among Others

COVID-19 Impact on Global Biosurgery Market:

Owing to the growing incidence of COVID-19, hospitals became high-risk zones, specifically for patients suffering from chronic conditions. As a result, non-critical procedures such as elective surgeries were either canceled or postponed during the first and second quarter of 2020, which resulted in a significant decline in the total number of elective surgical procedures performed. As a result, the demand for biosurgery products witnessed a sharp decline in 2020. The second wave of COVID-19 further deprioritized elective surgical procedures. Governments across the globe have also issued limitations and bans on medical procedures and elective surgeries. With the current pandemic scenario, surgical procedures have witnessed a decline and are only expected to increase in the third quarter of 2021 in countries such as the US. Some countries in the EU have resumed surgical interventions, which has increased the demand for biosurgery products in the region.

The study categorizes the biosurgery market based on product, application, end user, and regional and global level:

Global Biosurgery Market, by Product

  • Bone Graft Substitutes
    • Demineralized bone matrix
    • Synthetic Bone Grafts
    • Bone Morphogenetic Proteins
    • Other Bone-Graft Substitutes
  • Soft-tissue attachments
    • Synthetic meshes
    • Biological meshes
      • Allografts
      • Xenografts
  • Hemostatic agents
    • Thrombin-based hemostatic agents
    • Oxidized regenerated cellulose-based hemostatic agents
    • Combination hemostatic agents
  • Surgical sealants and adhesives
    • Natural/Biological Sealants and Adhesives
      • Natural/Biological Sealants and Adhesives, By Type
        • Fibrin Sealants
        • Collagen-Based Sealants
        • Gelatin-Based Sealants
        • Albumin-Based Sealants
        • Other Natural/Biological Sealants
      • Natural/Biological Sealants and Adhesives, By Origin
        • Human Blood-Based Sealants and Adhesives
        • Animal-Based Sealants and Adhesives
    • Synthetic and Semi-Synthetic Sealants and Adhesives
      • Peg Hydrogels
      • Cyanoacrylate-Based Sealants and Adhesives
      • Urethane-Based Sealants and Adhesives
      • Other Synthetic and Semi-Synthetic Sealants and Adhesives
  • Adhesion Barriers
    • Synthetic Adhesion Barriers
      • Hyaluronic Acid-Based Adhesion Barriers
      • Regenerated Cellulose-Based Adhesion Barriers
      • Peg-Based Adhesion Barriers
      • Other Synthetic Adhesion Barriers
    • Natural Adhesion Barriers
      • Collagen & Protein Adhesion Barriers
      • Fibrin-Based Adhesion Barriers
  • Staple-Line Reinforcement Agents

Global Biosurgery Market, by Application

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Urological Surgery
  • Thoracic Surgery
  • Others

Global Biosurgery Market, by End User

  • Hospitals
  • Clinics
  • Others

PDF Download: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302

Some of the key geographies mentioned in this report include:

  • North America (U.S and Canada and rest of North America)
  • Europe (Germany, France, Italy, and Rest of Europe)
  • Asia Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific)
  • LAMEA (Brazil, Turkey, Saudi Arabia, South Africa, and Rest of LAMEA)

The report covers exhaustive analysis on:

  • Overview of the parent market
  • Global Biosurgery Market Segments, Dynamics, Market Size, Share, Price, Volume, and Cost
  • Historical, current, and projected market size in terms of volume and value
  • Global Biosurgery Market Forecast 2021 to 2026
  • Supply & Demand Value Chain
  • Global Biosurgery Market dynamics, including the current trends / drivers / threats / restraints / challenges
  • Potential and niche segments/regions exhibiting promising growth
  • Market landscape, competition, and leading companies involved
  • Strategies of leading companies and product offerings
  • Technological advancements

Relate to Healthcare Industry Study:

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road, Suite 430, Northbrook, IL 60062

USA: 1-888-600-6441 | sales@marketsandmarkets.com

Post in: Health
Topics: biosurgery